How many institutional investors hold ABT?

1 tracked institutional investor disclosed a position in ABT (ABBOTT LABORATORIES) in their most recent 13F filing.

Who is the largest institutional holder of ABT?

Ray Dalio, Bridgewater Associates, holds the largest disclosed position in ABT, valued at $12M.

What sector is ABT in?

ABBOTT LABORATORIES is classified in the Health Care GICS sector.

Where does this ABT ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

ABT — ABBOTT LABORATORIES

Name: ABBOTT LABORATORIES (ABT) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Health Care

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About ABBOTT LABORATORIES (ABT)

ABBOTT LABORATORIES (ABT) appears in the most recent 13F filings of 1 tracked institutional investor. ABBOTT LABORATORIES is classified in the Health Care sector. The largest disclosed position is held by Ray Dalio (Bridgewater Associates), valued at $12M. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Tracked investors reporting ABT

Investor	Firm	Shares	Market value	% of portfolio	As of
Ray Dalio	Bridgewater Associates	117.1K	$12M	0.05%	Mar 31, 2026

Ray DalioMar 31, 2026
Bridgewater Associates
Shares
117.1K
Value
$12M
% Portfolio
0.05%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Ray Dalio	New	—	$12M	May 15, 2026

Ray Dalio
New
$12MMay 15, 2026

Frequently asked questions

How many institutional investors hold ABT?: 1 tracked institutional investor disclosed a position in ABT (ABBOTT LABORATORIES) in their most recent 13F filing.
Who is the largest institutional holder of ABT?: Ray Dalio, Bridgewater Associates, holds the largest disclosed position in ABT, valued at $12M.
Did institutional ownership of ABT increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited ABT.
What sector is ABT in?: ABBOTT LABORATORIES is classified in the Health Care GICS sector.
Where does this ABT ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.